Sewer sampling, the authors say, could be expanded to track other infectious diseases such as H5N1 avian flu or mpox or to detect unexpected pathogens.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
A secondary analysis finds that metformin may hold some promise.
A related study in South Korea shows waning vaccine effectiveness in teens.
A new study offers a complex picture of COVID-19 incidence among the US homeless population and illustrates the difficulty of tracking disease spread among this population. The study was published today in JAMA Network Open and found the incidence of the disease lower than among the general population.
The lack of awareness "likely had a role in rapid transmission," the authors note.
After COVID-19 issues, the CDC has a plan to prioritize public health and outbreak response.
Using a test-to-stay (TTS) strategy in K-12 schools during the winter of 2021-22 resulted in substantial reduction in missed school days, according to a study yesterday in Pediatrics.
Hospitalized adult COVID-19 patients before and after SARS-CoV-2 vaccine availability had significantly higher odds of venous—but not arterial—thromboembolism than those hospitalized for influenza before the pandemic, finds a study published today in JAMA.
A study of more than 2,900 healthcare workers (HCWs) shows that those who wore a respirator were more than 40% less likely to be infected with COVID-19 than those wearing a surgical mask.
Rates of severe pregnancy-related complications and severe maternal illness and death rose significantly.
Following the Food and Drug Administration (FDA) emergency use authorization (EUA) of the Novavax COVID-19 vaccine last month for the primary vaccine series, the company announced today that it has applied for an EUA for the vaccine to also be used as a booster in adults ages 18 and older.
